-
Chiesi Global Rare Diseases Announces European Commission Approval of LOJUXTA® (lomitapide) ▼ Capsules for Paediatric Use in Homozygous Familial Hypercholesterolaemia (HoFH)
European Commission approval expands the indication of lomitapide in the European Union (EU) to include children 5 years of age and older with HoFH, an ultra-rare genetic disorder affecting LDL-cholesterol levels June 05, 2026 02:00 ET | Source: Chiesi Global Rare Diseases PARMA, Italy, June 05, 2026 (GLOBE NEWSWIRE) — Chiesi Global Rare Diseases, a…
-
Healthcare experts call for bold national action to tackle children’s inactivity crisis
The Class of 2035 Commission warns children’s inactivity levels – driving rising anxiety, poor development and chronic conditions – are at a tipping point The Class of 2035 Commission, convened by Youth Sport Trust and bringing together leading voices from across healthcare to address growing challenges in children’s health and wellbeing, has today published its…
-
Tees Valley Tennis Foundation registered as a charity
11 May, 2026: Teesside, England: The Tees Valley Tennis Foundation (TVTF) has been officially registered with the Charity Commission, marking the formal launch of its work to support young tennis and padel players across the Tees Valley and the surrounding area. The Foundation will provide financial assistance to young players whose progress might otherwise be…
Latest News
About the Author
We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.
